General Archive
-
News releases£1 million partnership aims to develop new treatments for congenital muscular dystrophy
Researchers from University College London have jointly received a £1 million grant from LifeArc and Muscular Dystrophy UK, to develop…
-
Muscular Dystrophy UK: A £1 million partnership to find new treatments for congenital muscular dystrophy
Muscular Dystrophy UK: A £1 million partnership to find new treatments for congenital muscular dystrophy We’ve partnered with Muscular Dystrophy…
-
DefINe: A clinical trial to explore treatment for a rare genetic brain disorder
DefINe: A clinical trial to explore treatment for a rare genetic brain disorder The DefINe trial, launched by the University…
-
Prospective evaluation of KARSARC -a gene expression-based risk classifier for patients with soft tissue sarcomas treated with pazopanib
-
FARGO: FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis
-
TIARA: Autologous Tregs for Aplastic Anaemia
-
The CADET Trial: The Children’s Adaptive Deep brain stimulation for Epilepsy Trial
-
STOPFOP: Saracatinib trial TO Prevent FOP
-
Gene Therapy with Modified Autologous Hematopoietic Stem Cells for Patients with Mucopolysaccharidosis Type II
-
Phase II Study of a Novel Vitamin Metabolite (CoA-Z) for Pantothenate Kinase Associated Neurodegeneration
-
DefINe: A trial to test the use of deferiprone in people with neuroferritinopathy
-
The TIARA trial: Investigating a new treatment for a life-threatening blood disorder
The TIARA trial: Investigating a new treatment for a life-threatening blood disorder A collaboration with the Aplastic Anaemia Trust to…